• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Ketogenic diets and Alzheimer’s disease

    2017-04-04 15:52:25KlusLngeKthrinLngeEwelinMkulskGertrudYukikoNkmurAndresReissmnnShigehikoKnyJohimHuser

    Klus W.Lnge,Kthrin M.Lnge,Ewelin Mkulsk-Gertrud,Yukiko Nkmur,Andres Reissmnn,Shigehiko Kny,Johim Huser

    a Department of Experimental Psychology,University of Regensburg,93040 Regensburg,Germany

    b Department of Psychology,University of Winchester,UK

    c Graduate School of Information Science,Nara Institute of Science and Technology,Japan

    Abstract Alzheimer’s disease(AD)is a progressive neurodegenerative disorder characterized by decline in cognitive functions and associated with the neuropathological hallmarks of amyloid β-peptide plaques and neurofibrillar tangles.Cerebral glucose uptake and metabolism deteriorate in AD and this hypometabolism precedes the onset of clinical signs in AD.The early decline in brain glucose metabolism in AD has become a potential target for therapeutic intervention.This has led to investigations assessing the supplementation of the normal glucose supply with ketone bodies which are produced by the body during glucose deprivation and can be metabolized by the brain when glucose utilization is impaired.The present review provides a synopsis of preclinical studies and clinical trials assessing the effica y of ketogenic diets in the treatment of AD.Both the direct administration of ketone bodies and the use of high-fat,low-carbohydrate ketogenic diets have been shown to be efficaciou in animal models of AD and clinical trials with AD patients.The mechanism underlying the effica y of ketogenic diets remains unclear,but some evidence points to the normalization of aberrant energy metabolism.At present there is only limited evidence of the usefulness of ketogenic diets in AD.However,this dietary approach seems to be promising and deserves further clinical investigations.

    Keywords:Alzheimer’s disease;Ketone bodies;Ketogenic diet;Therapy

    1.Introduction

    Alzheimer’s disease (AD) is a chronic neurodegenerative disease and the most common cause of dementia,accounting for over 50% ofindividuals affected [1].This disease is characterized by progressive memory impairment and cognitive decline interfering with daily life activities.The most common early symptom of AD is difficult remembering recent events.The symptoms of patients with advancing disease can include executive dysfunction,disorientation,problems with language,mood swings,behavioral changes and impaired self-care [2].Age-standardized prevalence for individuals aged over 60 years varied between 5%and 7%in most world regions[3].An estimated 35.6 million people lived with dementia worldwide in 2010,with numbers expected to almost double every 20 years[3].

    AD has a long preclinical phase of several decades and the most important risk factor for AD is increasing age.Impaired vascular health has been shown to be another major risk factor for cognitive decline and interventions for cardiovascular risk may therefore improve cognitive health at the population level[4,5].Other lifestyle-related factors,such as obesity,diabetes,smoking,diet,physical and mental inactivity,have been suggested to play a role in dementia,and potential preventive measures related to these risk factors should be investigated[6].

    AD is neuropathologically define by neuronal loss and the accumulation of extracellular amyloid β-peptide (Aβ)-containing plaques and intracellular hyperphosphorylated tau protein-containing neurofibrillar tangles in the brain [7].The accumulation of abnormally folded Aβ and tau proteins in amyloid plaques and neuronal tangles,respectively,appear to be causally associated with the neurodegeneration in AD[8].However,a linear causality between amyloid and tau and AD seems to be too simplistic an assumption made by the original amyloid hypothesis[9].The cognitive decline in AD is associated with progressive synaptic dysfunction and neuronal atrophy,mainly in the neocortex,limbic system and subcortical brain areas[7].

    The etiology of AD is unknown,but both genetic and environmental risk factors have been suggested to be involved.Genome-wide association studies have shown more than 20 genetic loci to be associated with the risk of AD[10].The identifie AD risk genes are related to lipid and cholesterol processing,inflammator responses and the immune system.The majority of these genes affect Aβ production and clearance,emphasizing the special role of this pathway in the pathogenesis of AD.Carriers of the presenilin 1 mutation have the highest risk of AD [10].Another major susceptibility gene is the apolipoprotein E(ApoE)gene which is related to sporadic late-onset AD,the epsilon 4 (E4) variant of ApoE was found to increase the risk for AD[10].

    Curative therapies for AD are not available and supportive care plays an important role in the treatment of patients with AD.Symptomatic treatments providing temporary alleviation of the symptoms of AD without modifying the disease progression include drugs such as acetylcholinesterase inhibitors and the glutamate antagonist memantine [1].Most of these drugs offer at best a moderate symptomatic effect.Other therapeutic strategies focus on anti-amyloid approaches,including active and passive immunization,γ-secretase and β-secretase inhibitors,and antiaggregation drugs[1].A further understanding of the etiopathogenesis of AD is needed in order to develop disease-modifying therapies which can prevent,delay or treat the symptoms of AD.Type 2 diabetes and insulin resistance are the main lifestyle-related risk factors for AD.Lifestylemodifying approaches including diet and physical exercise may show beneficia effects in the prevention and early treatment of AD.

    The accumulation of Aβ and the development of AD have been proposed to be related to dietary factors.For example,the finding of a Dutch study suggested that diets rich in saturated fat and cholesterol increase the risk of several types of dementia[11].However,a subsequent 6-year follow-up of the same study population found no correlation between fat consumption and dementia[12].Another large study of elderly participants found only weak trends between cognitive decline and the intake of saturated fat and cholesterol as assessed using a food questionnaire[13].

    The finding of recent investigations have suggested that caloric restriction prevents age-related neuronal damage and may be useful in the prevention and treatment of AD [14].Hypotheses linking caloric restriction to cognitive capability include anti-inflammator mechanisms,reduction of neural oxidative stress,promotion of synaptic plasticity as well as induction of various stress and neurotrophic/neuroprotective factors [14].Caloric restriction may also prevent Aβ neuropathology in AD transgenic animal models [14].A relative recent dietary approach to the treatment of AD is the administration of ketogenic diets.

    2.Development of ketogenic diets

    During infancy and early childhood,ketone bodies play an important role beside glucose as oxidizable substrates and energy source for the brain[15]since their blood plasma concentrations are high and an abundance of monocarboxylic acid transporters render the blood–brain barrier greatly permeable to ketone bodies[16].In adult humans,high ketone body concentrations are found during fasting and on a high-fat diet.In addition,the permeability of the blood–brain barrier increases with fasting[16].Ketone bodies when present at sufficien concentrations to saturate metabolism can support most,if not all,basal(non-signaling)neuronal energy needs and up to approximately half of the activity-dependent oxidative needs of neurons[17].

    When food was scarce,ketosis may have been a survival mechanismduringhumanevolution[18].Foodscontaininglarge amounts of carbohydrates have relatively recently become a part of the human diet and may be more evolutionarily discordant than high fat diets[19].High carbohydrate diets stimulate insulin signaling and lead to a suppression oflipid metabolism and ketogenesis [20].The evolutionary switch to diets high in carbohydrates(ketodeficien diet)has been hypothesized to play a role in the development of AD[21].

    It has long been known that fasting has anticonvulsant properties.The ketogenic diet was developed in the 1920s to mimic the physiological alterations observed in prolonged fasting[22]when energy is mainly derived from the utilization of body fat or dietary fat.This diet was successfully used as a therapeutic approach for seizures[23].Due to the availability of antiepileptic drugs the ketogenic diet was not in use for decades,but was in favor again in the 1990s,particularly in the therapy of pharmacoresistant epilepsy.The ketogenic diet is very high in fat and low in carbohydrates and is believed to simulate the effects of starvation by primarily metabolizing fat as energy supply[24].While fasting the organism metabolizes stored body fat via lipolysis and the ensuing β-oxidation of fatty acids leads to the production of acetoacetate,β-hydroxybutyrate and acetone which can easily cross the blood–brain barrier.These ketone bodies can be used as precursors for the generation of adenosine triphosphate(ATP).

    The ketogenic diet has now become an established and effective nonpharmacological treatment for epilepsy [25–27].A number of patients with intractable epilepsy have been shown to become seizure-free or to have a significan reduction in seizure frequency during the administration of a ketogenic diet and even following the discontinuation of the diet,suggesting disease-modifying effects in some patients with epilepsy [27].Several mechanisms underlying the anticonvulsive effects of ketone bodies have been proposed [27],including changes in ATP production,altered brain pH affecting neuronal excitability,direct inhibitory effects of ketone bodies or fatty acids on ion channels,and shifts in amino acid metabolism [28–30].Since at least some glucose is required for the synthesis of glutamate and the maintenance of homeostasis during glutamatergic activity[31],a ketogenic diet very low in carbohydrates may prevent seizures by compromising the formation of the excitatory neurotransmitter glutamate(for further details see Ref.[32]).This hypothesis is supported by the fact that the replacement of glucose by β-hydroxybutyrate in the medium decreases glutamate availability in cultured neurons[33].

    Beside its effica y in the treatment of refractory epilepsy,the ketogenic diet has been suggested to be useful in the therapy of neurodegenerative and neuromuscular diseases including AD,Parkinson’sdisease,amyotrophiclateralsclerosisandmitochondrial disorders[34].The ketogenic diet is likely to have different mechanisms in different diseases[29].

    3.Rationale for the use of ketogenic diets in AD

    Energy deprivation is harmful to neurons and may contribute to the pathophysiology of AD since brain glucose uptake and metabolism have been shown to be impaired in AD.A decline in cerebral blood flw and mean cerebral oxygen utilization was found to be correlated with increasing severity of dementia[35].Compared to elderly controls,individuals with senile dementia showed a decrease in regional glucose use in the posterior cingulate,temporal,parietal and prefrontal cortex[36]and this hypometabolism correlated significantl with measures of cognitive functioning[37].The defici in brain glucose metabolism is an early feature of AD and could be the consequence of a reduced need for glucose due to synaptic loss and neuronal cell death.However,brain glucose hypometabolism has also been observed in preclinical stages of AD long before the occurrence of cognitive deficits Clinical studies have reported a decline in cerebral glucose utilization prior to the onset of clinically measurable cognitive decline and the diagnosis of AD[38,39].Brain hypometabolism preceding the onset of clinical signs of AD may presymptomatically contribute to the risk of AD[40].Early degeneration of the locus coeruleus,the noradrenergic brain stem nucleus,may be a reason for the compromised glucose metabolism in AD since the locus coeruleus stimulates glucose metabolism,at least in astrocytes (for review see Ref.[41]).Glucose metabolism has also been shown to decrease in healthily aging individuals,but the reduction is more pronounced in ApoE4 carriers than in matched non-carriers [42].A low regional cerebral metabolic rate of glucose appears to occur early in the AD process long before the onset of clinical signs of dementia or neuronal loss and plaque deposition in the brain[43].Brain hypometabolism has been suggested to indicate a risk for the future development of dementia [44].A vicious circle may gradually develop in which latent presymptomatic brain hypometabolism leads to chronic brain energy deprivation,deteriorating neuronal function,further decline in demand for glucose and progression of cognitive impairment[40].The reason why reduced brain glucose metabolism develops is unknown,but defective brain glucose transport,disrupted glycolysis,or impaired mitochondrial function may be involved(for a detailed account of the consequences ofimpaired energy metabolism in AD see Ref.[32]).Mitochondrial DNA is maternally inherited in humans,and it is therefore noteworthy that reduced brain glucose metabolism before the onset of cognitive decline is more pronounced in elderly individuals with a maternal family history of AD than in those with paternal or no family history[45].

    The adult human brain represents about 2% of total body weight but requires approximately 20% of the entire body’s supply of energy.It relies almost exclusively on glucose as energy substrate and stores only small amounts of glycogen.Fatty acids cannot cross the blood–brain barrier and are not available as energy source in the brain.Although glucose is the brain’s major fuel,the ketone bodies β-hydroxybutyrate and acetoacetate produced by the liver from fatty acids can be used as replacement for glucose during starvation,fasting or demanding exercise[18,46].Fasting or an intake of very small amounts of carbohydrates induces ketosis due to hepatic β-oxidation oflong-chain fatty acids.In comparison to glucose,ketone bodies produce a larger amount of energy due to changes in mitochondrial ATP production that they induce [47,48].Ketone bodies can bypass the block in glycolysis caused by impaired insulin function [49].While glucose hypometabolism has repeatedly been demonstrated in patients with AD [24],the metabolism of ketone bodies was unchanged,at least in the early disease stages[50].In a state of brain energy crisis,ketone bodies can be used as an auxiliary and alternative fuel for brain metabolism[16].Since fuel hypometabolism in the AD brain appears to be specifito glucose,the administration of ketone bodies may overcome the reduction in glucose uptake and metabolism and improve the energy defici in the brain.Both calorie restriction and consumption of a ketogenic diet reduce carbohydrate intake and lead to a compensatory rise in ketone bodies.This has been shown to improve mitochondrial function,reduce the expression of apoptotic and inflammator mediators and increase the activity of neurotrophic factors[51].Dietary carbohydrate reduction appears to have neuroprotective effects [52]and ketone bodies have been demonstrated to protect neurons against multiple types of neuronal injury and to have mitochondrial effects similar to those following calorie restriction or ketogenic diet[51].In summary,an increase in ketone body supply,provided by a ketogenic diet or by the administration of ketone esters,would be expected to alleviate the impaired brain glucose metabolism preceding the onset of AD.

    4.Ketone bodies in a cell culture model of AD

    Neuroprotective properties of ketone bodies have been investigated in cell cultures.A proteolytic fragment of the β chain of amyloid precursor protein,Aβ1–42,is toxic to hippocampal cells.The exposure of 6-day cultured hippocampal neurons from 18-day-old embryos to 5 μM Aβ1–42 reduced cell number as well as neurite number and length compared to control[53].When the cells were simultaneously exposed to 4 mM Dβ-hydroxybutyrate,the surviving cell number doubled and both cell size and neurite outgrowth increased in comparison with cells exposed to Aβ1–42 alone [53].These finding show that β-hydroxybutyrate may provide neuroprotection from Aβ1–42 toxicity.In addition,exposure of cells to ketone bodies for 14 h increased both surviving cell number and neurite number compared to control cells,suggesting that ketone bodies can act as growth factors to neurons in culture[53].The ability of ketone bodies to protect neurons in culture suggests that defects in mitochondrial energy generation contribute to the pathophysiology of AD and that ketone bodies may have therapeutic potential.This needs to be investigated using in vivo studies.

    5.Ketogenic diets in animal models of AD

    Animal models have provided insight into the underlying mechanisms of AD and have been useful in the preclinical evaluation of potential treatments[54].Genetically modifie animals exhibiting critical aspects of AD neuropathology have helped understand the function of genes associated with AD.Several studies have used genetically modifie rodents as AD models in order to assess the therapeutic effica y of ketogenic diet and ketone bodies in regard to pathological changes and behavioral deficits

    In a transgenic mouse model,the effects of a ketogenic diet composed of very high saturated fat and extremely low carbohydrate content were investigated [55].These mice exhibit significan levels of soluble Aβ at three months of age and extensive plaque deposition at age 12–14 months [56].Two groups of female transgenic mice carrying the “London” APP mutation (APP/V717I) were fed ad libitum for 43 days either a standard diet composed of high carbohydrate/low fat chow or a ketogenic diet composed of very low carbohydrate/high saturated fat chow[55].Animals fed the ketogenic diet showed greatly increased serum ketone body concentrations and significantly reduced brain Aβ40 and Aβ42 levels while no changes in cognitive performance were found[55].The findin that Aβ reduction did not improve cognitive performance may be due to the relatively short intervention.Long-term administration of the ketogenic diet may be required in order to produce behavioral effects.

    Another study assessed the effects of a ketogenic diet in two transgenic mouse lines[57].Five-month-old APP/PS1 mice(model of amyloid deposition)and Tg4510 mice(model of tau deposition) were fed either a ketogenic or a control diet for three months.Behavioral testing during the last two weeks of treatment showed that mice fed the ketogenic diet performed significantl better on a rotarod than those in the control group independent of genotype [57].In the open fiel test,both transgenic mouse lines presented increased locomotor activity compared to nontransgenic,age-matched controls,and this effect was not influence by the ketogenic diet[57].The radial arm water maze identifie learning deficit in both transgenic lines without significan differences between the diets.Tissue measures of amyloid,tau,astroglial and microglial markers in transgenic lines showed no differences between mice fed the ketogenic or control diet[57].These finding suggest that ketogenic diets may play a role in enhancing motor performance in the two mouse models while not affecting amyloid or tau deposition.

    An effect on amyloid or tau deposition may not be necessary in order to achieve improvements in cognitive functions following dietary interventions.In the triple-transgenic mouse model ofAD(3xTgADmice),twodifferentenergyrestrictionregimens(40%calorie restriction and intermittent fasting)were tested in regard to their ability to protect against cognitive decline[58].Groups of 3xTgAD mice were maintained on calorie restriction,intermittent fasting or an ad libitum control diet starting at three months of age.Half of the mice in each diet group were tested using the open fiel and the Morris swim task at age 10 months and the other half at 17 months [58].At 10 months 3xTgAD mice on the control diet showed reduced exploratory activity compared to non-transgenic mice and 3xTgAD mice on calorie restriction and intermittent fasting [58].No significan differences were found in performance in the water maze between genotypes or diets in 10-month-old mice[58].In 17-month-old 3xTgAD mice,the calorie restriction and intermittent fasting groups exhibited higher levels of exploratory behavior and better performance in the swim task,compared to 3xTgAD mice on the control diet[58].3xTgAD mice in the calorie restriction group showed lower levels of Aβ1–40,Aβ1–42 and phosphorylated tau in the hippocampus compared to the control diet group,while Aβ and phosphorylated tau levels were not decreased in 3xTgAD mice in the intermittent fasting group[58].These find ings suggest that intermittent fasting,which may increase levels of ketone bodies,can ameliorate age-related cognitive deficit without affecting Aβ or tau levels.

    Medium chain triglycerides are easily converted to ketone bodies.A study assessing the effects of ketosis induced by the administration of medium chain triglycerides was performed in aged dogs,a natural model of amyloidosis [59].The dogs received a 2 g/kg/day dose of medium chain triglycerides for 2 months.Compared to age-matched controls,markedly improved mitochondrial function was observed in aged dogs receiving medium chain triglycerides [59].This effect was most prominent in the parietal lobe.In addition,there was a trend towards a decrease in Aβ levels in the parietal lobe[59].These results suggest that short-term administration of medium chain triglycerides improves energy metabolism in the aged canine brain.

    Mitochondrial bioenergetic deficit have been shown to be closely related to the pathogenesis of AD [60].These deficit activate a cascade of neurotoxic outcomes,including an increase in oxidative stress and the production of Aβ,which impair synaptic functions and lead to neuronal death [61].A decline in mitochondrial bioenergetics has also been demonstrated to precede AD pathology in the female triple-transgenic AD(3xTgAD)mouse model[62].In the brains of these mice,a temporary increase in the expression of ketogenic markers was also found,indicating a compensatory energy production mechanism[62].In order to investigate if this alternative energy supply could be preserved,the effects of 2-deoxy-D-glucose (2-DG)administration on brain AD pathology were assessed [63].2-DG is known to competitively block glucose metabolism and to induce ketogenesis in the liver,i.e.a compensatory production of ketone bodies as alternative energy substrates.

    Six-month-old female 3xTgAD mice were fed either a diet containing 0.04%2-DG or a regular diet(AIN-93G)for seven weeks.The 2-DG diet markedly increased serum ketone body levels and brain expression of enzymes required for ketone body metabolism.Mice fed the 2-DG diet showed a significan reduction of both amyloid precursor protein (APP) and amyloid beta (Aβ) oligomers as well as a significan increase in α-secretase and decrease in γ-secretase expression,indicating that 2-DG induced a shift towards a non-amyloidogenic pathway[63].In comparison to the control diet,the 7-week dietary 2-DG administration significantl induced ketogenesis,sustained mitochondrial bioenergetic function,and reduced Aβ pathology.In summary,these preclinical finding suggest that the dietary 2-DG intervention can delay the progression of bioenergetic deficit and Aβ production in the brain[63].

    The hypothesis that a ketone ester-based diet can ameliorate AD pathogenesis was tested in the 3xTgAD mouse model[64].Beginning at a presymptomatic age,male 3xTgAD mice were fed either a diet containing a physiological enantiomeric precursor of ketone bodies or an isocaloric carbohydrate diet.The mice fed a precursor of ketone bodies showed reduced Aβ and hyperphosphorylated tau deposition in the hippocampus,amygdala and cortex [64].In behavioral tests performed at 4 and 7 months following the initiation of the experimental diet,3xTgAD mice exhibited significan improvements in learning and memory tests as assessed using the Morris water maze [64].These results demonstrate that long-term feeding of ketone esters reduces Aβ accumulation and hyperphosphorylated tau pathology and improves cognitive functions in a mouse model of AD.The preclinical finding suggest that a ketone ester-containing diet can potentially retard the disease process and improve cognitive functions of patients with AD.

    Ketone bodies cannot provide additional citric acid cycle intermediates which limits the anabolic capacity of the cell.The supplementation of ketogenic diet with anaplerotic compounds such as triheptanoin may increase the effects of the diet[65].The hypothesis that supplementation with triheptanoin can increase the beneficia effects of ketogenic diet was tested in a rodent model of familial AD,the APP/PS1 transgenic mouse.Three-month-old APP/PS1 mice were fed a ketogenic diet plus triheptanoin supplementation for three months.This treatment reduced the memory impairment of the mice at the age of 6 months.Aβ production and deposition were not significantl changed by either ketogenic diet alone or the combination diet[65].However,mice fed with triheptanoin-rich ketogenic diet demonstrated a reduction in astroglial response in the vicinity of Aβ plaques and a decrease in the expression of the pro-inflammator cytokine interferon-γ in astrocytes.Ketogenic diets supplemented with anaplerotic compounds may therefore delay cognitive impairment by acting via astrocytes in energy metabolism responses[65].These results suggest the potential therapeutic utility of triheptanoin-rich ketogenic diets at early stages of AD.

    In summary,several reports have indicated neuroprotective properties of ketone bodies in animal models of AD.However,the translational concordance between these preclinical studies and clinical trials in humans needs to be investigated.

    6.Clinical trials of ketogenic diets in AD

    As shown above,several strategies are available in order to induce ketosis,i.e.the administration of (1) high-fat,lowcarbohydrate,low-protein,ketogenic diets,(2) medium chain triglycerides,and(3)ketone bodies.These approacheshavebeen usedinafewclinicaltrialsassessingtheeffica yofketonebodies in patients with AD.

    Oral administration of medium chain triglycerides has been shown to induce ketosis in humans[66].Due to their short fatty acid chain lengths,medium chain trigycerides do not underlie the regulation imposed on long chain fatty acids and they undergo obligatory oxidation.When fatty acids are oxidized at high rates,large amounts of acetyl coenzyme A are generated.Following the intake of a sufficientl large amount of medium chain triglycerides,the excess acetyl coenzyme A produced exceeds the capacity of the citric acid cycle and leads to the synthesis of ketone bodies in liver mitochondria[67].In contrast to the ketogenic diet,medium chain triglycerides are oxidized regardless of the consumption of other nutrients,and a restriction of carbohydrate or protein intake is therefore not necessary.

    The effects of an increase in plasma ketone body levels on cognitive functions were investigated in older adults with memory disorders[66].Elevation of ketone levels was induced using an oral dose of medium chain triglycerides.On separate days,20 subjects with AD or mild cognitive impairment imbibed a drink containing emulsifie medium chain triglycerides or placebo.A significan increase in β-hydroxybutyrate levels was observed 90 min after administration when cognitive testing was performed.The increase in β-hydroxybutyrate was moderated by ApoE genotype[66].In ApoE4-positive participants,β-hydroxybutyrate levels continued to rise between the 90 and 120-min blood sampling in the treatment condition,while levels in ApoE4-negative subjects remained constant[66].The administration of medium chain triglycerides facilitated performance on the AD Assessment Scale-Cognitive Subscale in ApoE4-negative participants,but not in ApoE4-positive participants.Higher ketone values were associated with greater improvement in paragraph recall under medium chain triglyceride treatment relative to placebo across all participants [66].Future studies need to assess the therapeutic benefit of medium chain triglycerides and the mediation by ApoE-4 status in patients with AD.

    An oral ketogenic compound,AC-1202,was administered to individuals with probable AD in order to assess if chronic induction of mild ketosis can improve cognitive performance[68,69].AC-1202 is a form of medium chain triglycerides and elevates serum ketone bodies even in the presence of dietary carbohydrates.Daily administration of AC-1202 over 90 days was evaluated in 152 patients with a diagnosis of mild to moderate AD in a randomized,placebo-controlled,doubleblind,parallel-group study.The participants were on a normal diet and continued taking their usual AD medications.Primary cognitive end points were mean change from baseline in the AD Assessment Scale-Cognitive subscale(ADAS-Cog),and global scores in the AD Cooperative Study — Clinical Global Impression of Change (ADCS-CGIC).AC-1202 was compared to placebo in several population groups,including intention-to-treat (ITT),per protocol,and dosage compliant groups.The results were also stratifie by ApoE4 carriage status.AC-1202 significantl increased serum ketone bodies two hours after administration compared to placebo [68,69].Each population group showed a significan difference between AC-1202 and placebo in mean change from baseline in ADAS-Cog score on days 45 and 90.Effects were most notable in subjects who did not carry the ApoE4 allele,patients with the ApoE4 genotype did not benefit Adverse events were more frequently observed in participants receiving AC-1202 and concernedmainlytransient,mildtomoderategastrointestinaleffects[68,69].Insummary,theoralketogeniccompoundAC-1202was found to have memory-enhancing effects after 45 and 90 days of treatment.This medium-chain triglyceride preparation of fractionated coconut oil(caprylic trigyceride)has been approved for the treatment of AD in the USA[70].

    In another study,ketosis was induced by a diet very low in carbohydrates[71].Twenty-three older adults with mild cognitive impairment were randomly assigned to either a high carbohydrate or very low carbohydrate diet.Following the 6-week intervention period,improved verbal memory performance was observed in participants receiving the low carbohydrate diet[71].Changes in calorie intake,insulin level,and weight were not correlated with memory performance for the entire sample,although a trend toward a moderate relationship between insulin and memory was observed within the low carbohydrate group[71].Ketone levels were positively correlated with memory performance [71].These finding indicate that a very low carbohydrate diet can improve memory function in older adults with increased risk for AD.The mechanism of action underlying this cognitive change remains to be established.

    A new way to produce therapeutic hyperketonemia has recently been described [72].In a 63-year-old patient with younger-onset sporadic AD for 12 years and a pretreatment Mini-Mental State Examination score of 12,a firs trial was conducted of prolonged oral administration of a potent ketogenic agent,(R)-3-hydroxybutyl(R)-3-hydroxybutyrate(ketone monoester) [73].This ketone monoester has been shown to improve cognitive performance and reduce Aβ and tau deposition in cognition-relevant areas in a mouse model of AD[64].The compound was administered as a food supplement without changes in the habitual diet.In the 20-month trial,the ketone ester produced repeated diurnal increases in plasma βhydroxybutyrate levels and improved cognitive performance,mood,affect,behavior and activities of daily living[72].Plasma ketonelevelsandthepatient’sperformanceseemedtoberunning parallel,with interaction and conversation improving noticeably at higher levels and declining as ketone concentrations approached baseline.Anincrease inthepatient’sself-sufficien y and a reduced need for supervision were also noted[72].However,properly designed case–control studies need to confir these observations.

    In summary,a moderate improvement in AD symptoms has been found following dietary supplementation with relatively low concentrations of ketone bodies.In individuals with epilepsy,the highest possible portion of the calorie need may have to be provided in the form of ketone bodies in order to decrease glucose metabolism sufficientl to compromise glutamate production in neurons.By contrast,much lower amounts of ketone bodies can have therapeutic effects in AD probably by different mechanisms.The smaller ketone body doses administered in AD may owe their effect mainly to the support of energy metabolism,but they might also inhibit the release of gliotransmitter glutamate[32].

    7.Possible problems with ketogenic diets in AD

    Physicians are commonly afraid of ketosis because severe hyperketonemia induced by insulin deficien y may be a lifethreatening condition in patients with type 1 diabetes.It is,however,important to distinguish between diabetic ketoacidosis and nutritional ketosis(“physiological ketosis”[74]).Ketoacidosis is a pathological metabolic state characterized by extreme ketosis which cannot be adequately regulated due to a lack ofinsulin.The resulting pH imbalance may be fatal.However,this kind of metabolic derangement is not possible in ketosis induced by dietary changes.

    The evaluation of side effects of ketogenic diets in patients with AD is difficul due to the small number of available clinical trials.Major adverse reactions have not been reported in the literature.Transient,mild to moderate gastrointestinal effects such as diarrhea,dyspepsia,and flatulenc were reported in patients receiving a formulation of medium chain triglycerides[68,69].The administration of a ketogenic diet to 83 obese patients for 24 weeks did not produce any significan adverse effects[75].

    Strict adherence to low carbohydrate consumption is needed in ketogenic diets.This may be difficul for AD patients due to theiralteredfoodpreferencetowardcarbohydrate-richandsweet foods[76,77].The administration of medium chain triglycerides in order to induce ketosis may be favorable in AD since there is no need for dietary change.

    8.Conclusions and future directions

    More than 50%of all dementia cases are caused by AD.There are currently no therapies available to prevent or at least delay the progression of the disease.The early and region-specifidecline in brain glucose metabolism in AD has become a potential target for therapeutic intervention.This has led to investigations assessing the supplementation of the normal glucose supply with ketone bodies which are produced by the body during glucose deprivation and can be metabolized by the brain when glucose utilization is impaired.

    The toxic effects of Aβ1–42 on hippocampal neurons in culture were reversed by D-β-hydroxybutyrate,suggesting that ketone bodies may have neuroprotective effica y [53].Some animal studies have shown that high-fat diets are associated with elevated Aβ loads[78,79]while decreased Aβ levels were observed following the administration of a ketogenic diet high in saturated fat and very low in carbohydrates[55].These seemingly conflictin finding can be explained by the fact that,in the earlier studies,fat was added to the diet without a marked reduction in carbohydrates.Dietary strategies attempting to decrease Aβ levels should therefore consider the interactions of dietary componentsandtheirmetabolicoutcomes,i.e.totalcalories,carbohydrate levels and the production of ketone bodies need to be taken into account.The translational relevance of these finding should be confirme in clinical studies with AD patients.

    Data from clinical trials suggest that medium chain triglycerides improve cognition in patients with mild to moderate AD in ApoE4-negative patients[68,69].In order to establish the role of medium chain triglycerides in the therapy of AD,genetic screening including ApoE4 carriage status would have to be routinely performed in patients.A novel approach to induce therapeutic hyperketonemia is the administration of ketone monoesters[72].A case report using this method presented promising results.However,case–control studies need to confir this observation.

    Best results of dietary ketogenic approaches in AD may be expected by early presymptomatic treatment [80].However,a reliable diagnostic identificatio ofindividuals with minimal neuropathological alterations would be necessary.It is currently unclear whether or not cognitive decline can be delayed if brain hypometabolism is improved preclinically or early in the course of the disease.Future studies need to demonstrate that the neuroprotective properties of ketone bodies can influenc or prevent AD-related impairment of clinically relevant functions such as cognition.In this respect,there is at present only limited evidence of the usefulness of ketogenic diets in AD.However,this novel dietary approach seems to be interesting and deserves further clinical investigations in AD.

    老熟女久久久| 九九久久精品国产亚洲av麻豆| 精品国产露脸久久av麻豆| 汤姆久久久久久久影院中文字幕| 日本猛色少妇xxxxx猛交久久| 免费观看无遮挡的男女| 日本黄色片子视频| 少妇的逼水好多| 亚洲电影在线观看av| 久久国产乱子免费精品| 啦啦啦中文免费视频观看日本| 老司机亚洲免费影院| 久久精品国产亚洲av天美| 色5月婷婷丁香| av网站免费在线观看视频| 桃花免费在线播放| 伦理电影免费视频| 日本免费在线观看一区| 久久99热6这里只有精品| 国产免费视频播放在线视频| tube8黄色片| 99热6这里只有精品| 亚洲精品乱码久久久久久按摩| 亚洲国产色片| 国产免费视频播放在线视频| 午夜av观看不卡| 超碰97精品在线观看| 国产熟女午夜一区二区三区 | 免费av中文字幕在线| videos熟女内射| 国产精品人妻久久久久久| 国产亚洲91精品色在线| 欧美激情国产日韩精品一区| 九九在线视频观看精品| 亚洲三级黄色毛片| 人妻夜夜爽99麻豆av| 精品午夜福利在线看| 国产免费福利视频在线观看| 精品久久久噜噜| 国产乱来视频区| 麻豆精品久久久久久蜜桃| 99热这里只有是精品50| 有码 亚洲区| 国产乱来视频区| 亚洲精品国产色婷婷电影| 最近最新中文字幕免费大全7| 一级a做视频免费观看| 欧美精品国产亚洲| 午夜影院在线不卡| 久久久国产欧美日韩av| 久久久久久久久久成人| 免费观看在线日韩| 成人黄色视频免费在线看| 日日啪夜夜撸| 三级经典国产精品| 亚洲欧美日韩另类电影网站| 欧美 亚洲 国产 日韩一| 亚洲精品乱久久久久久| 久久久国产欧美日韩av| 午夜影院在线不卡| 人妻一区二区av| 色视频在线一区二区三区| 国产一区二区在线观看日韩| a 毛片基地| 久久久午夜欧美精品| av.在线天堂| 久久久久久久久久久久大奶| 高清黄色对白视频在线免费看 | 纯流量卡能插随身wifi吗| 天堂俺去俺来也www色官网| 丝袜在线中文字幕| 亚洲欧美日韩东京热| 亚洲欧美精品专区久久| 狂野欧美激情性xxxx在线观看| 51国产日韩欧美| h视频一区二区三区| 亚洲欧美一区二区三区黑人 | 国产精品国产三级国产av玫瑰| 男的添女的下面高潮视频| 各种免费的搞黄视频| 亚洲美女视频黄频| 成人国产av品久久久| 亚洲精品日韩在线中文字幕| 国产在视频线精品| 亚洲欧美中文字幕日韩二区| 一边亲一边摸免费视频| 看非洲黑人一级黄片| 丝瓜视频免费看黄片| 亚洲国产欧美日韩在线播放 | 亚洲精品一二三| 七月丁香在线播放| 亚洲av男天堂| 少妇人妻 视频| 欧美成人精品欧美一级黄| a 毛片基地| 久久精品国产a三级三级三级| 亚洲国产精品专区欧美| 精品国产露脸久久av麻豆| 伦理电影大哥的女人| 久久人妻熟女aⅴ| 一区在线观看完整版| 99热网站在线观看| 国内精品宾馆在线| 国产午夜精品一二区理论片| 只有这里有精品99| 成人无遮挡网站| 涩涩av久久男人的天堂| 亚洲av中文av极速乱| 偷拍熟女少妇极品色| 在线免费观看不下载黄p国产| 久久亚洲国产成人精品v| 中文欧美无线码| 丰满乱子伦码专区| 成人国产av品久久久| 欧美97在线视频| 女的被弄到高潮叫床怎么办| 免费黄频网站在线观看国产| 狠狠精品人妻久久久久久综合| 女的被弄到高潮叫床怎么办| 成人18禁高潮啪啪吃奶动态图 | 欧美激情极品国产一区二区三区 | 我的女老师完整版在线观看| 人人妻人人爽人人添夜夜欢视频 | 国产成人一区二区在线| 国产欧美日韩一区二区三区在线 | 国产精品一二三区在线看| av线在线观看网站| 一级av片app| 日韩电影二区| 日韩成人伦理影院| 制服丝袜香蕉在线| 国产 一区精品| 一边亲一边摸免费视频| 亚洲欧美中文字幕日韩二区| 成人午夜精彩视频在线观看| 肉色欧美久久久久久久蜜桃| 国产成人免费观看mmmm| 热re99久久国产66热| 免费看av在线观看网站| 久久鲁丝午夜福利片| av免费观看日本| 一区二区三区四区激情视频| 久久人人爽人人片av| 99久久精品一区二区三区| 高清黄色对白视频在线免费看 | 国产在线男女| 久久久亚洲精品成人影院| 国产高清国产精品国产三级| 啦啦啦啦在线视频资源| 国产在线男女| 国产色婷婷99| 人妻一区二区av| 日日啪夜夜撸| 五月玫瑰六月丁香| 亚洲欧洲精品一区二区精品久久久 | 一区二区三区乱码不卡18| 22中文网久久字幕| 22中文网久久字幕| 久久久亚洲精品成人影院| 91成人精品电影| 三上悠亚av全集在线观看 | 成人免费观看视频高清| 日韩 亚洲 欧美在线| 成人毛片60女人毛片免费| 男女免费视频国产| 欧美成人午夜免费资源| 女性被躁到高潮视频| 晚上一个人看的免费电影| 熟女人妻精品中文字幕| 亚洲国产精品一区三区| 国产乱来视频区| 亚洲性久久影院| 男女边摸边吃奶| 国产视频首页在线观看| 欧美日韩av久久| 观看免费一级毛片| 99re6热这里在线精品视频| 交换朋友夫妻互换小说| 国产免费一级a男人的天堂| 69精品国产乱码久久久| 欧美日韩视频高清一区二区三区二| 国产69精品久久久久777片| 日韩,欧美,国产一区二区三区| 哪个播放器可以免费观看大片| 亚洲欧洲精品一区二区精品久久久 | 欧美日韩亚洲高清精品| 成年人免费黄色播放视频 | 校园人妻丝袜中文字幕| 亚洲av综合色区一区| 免费黄频网站在线观看国产| 精品国产露脸久久av麻豆| 亚洲怡红院男人天堂| 我要看黄色一级片免费的| 涩涩av久久男人的天堂| 性高湖久久久久久久久免费观看| 亚洲激情五月婷婷啪啪| 国国产精品蜜臀av免费| 三级国产精品片| 亚洲无线观看免费| 少妇人妻一区二区三区视频| av又黄又爽大尺度在线免费看| 99久国产av精品国产电影| 精品亚洲成国产av| 久久久久久久久久人人人人人人| 深夜a级毛片| 美女xxoo啪啪120秒动态图| 日韩一区二区三区影片| 熟女av电影| 精华霜和精华液先用哪个| 男男h啪啪无遮挡| 少妇精品久久久久久久| 欧美精品人与动牲交sv欧美| 有码 亚洲区| 成人二区视频| 国产成人freesex在线| 五月伊人婷婷丁香| 精品少妇内射三级| 天堂俺去俺来也www色官网| 亚洲欧美精品专区久久| 多毛熟女@视频| 日韩免费高清中文字幕av| 亚洲内射少妇av| 一本久久精品| 亚洲国产成人一精品久久久| 亚洲国产精品999| 你懂的网址亚洲精品在线观看| 丝瓜视频免费看黄片| 午夜免费男女啪啪视频观看| 永久免费av网站大全| 亚洲激情五月婷婷啪啪| av专区在线播放| 久久鲁丝午夜福利片| 2022亚洲国产成人精品| 亚洲美女视频黄频| 91午夜精品亚洲一区二区三区| 成人特级av手机在线观看| 性色av一级| 十八禁高潮呻吟视频 | 成年人免费黄色播放视频 | 色婷婷av一区二区三区视频| 日韩大片免费观看网站| 老司机亚洲免费影院| 久久精品国产亚洲av天美| 精品国产露脸久久av麻豆| 黑人高潮一二区| 高清欧美精品videossex| 婷婷色av中文字幕| 久久久国产精品麻豆| 日本wwww免费看| 99久国产av精品国产电影| 亚洲国产欧美日韩在线播放 | 少妇的逼好多水| 一本—道久久a久久精品蜜桃钙片| 美女xxoo啪啪120秒动态图| 国产精品女同一区二区软件| 国产成人免费观看mmmm| 高清黄色对白视频在线免费看 | 国产成人免费无遮挡视频| 精品少妇内射三级| 啦啦啦在线观看免费高清www| 国产精品三级大全| 亚洲精品日本国产第一区| 99热网站在线观看| 在线观看免费高清a一片| 韩国高清视频一区二区三区| 99国产精品免费福利视频| 国产极品粉嫩免费观看在线 | 亚洲av电影在线观看一区二区三区| 久久久久久久国产电影| 亚洲成色77777| 成人18禁高潮啪啪吃奶动态图 | 精品亚洲成国产av| 国产伦精品一区二区三区视频9| 女性被躁到高潮视频| 成人亚洲精品一区在线观看| 一级毛片久久久久久久久女| 一级毛片aaaaaa免费看小| 日产精品乱码卡一卡2卡三| 午夜91福利影院| 日本黄色日本黄色录像| 亚洲精品乱久久久久久| 老熟女久久久| 一区二区av电影网| 欧美 日韩 精品 国产| 国产成人精品无人区| 91精品国产国语对白视频| a级片在线免费高清观看视频| 黑人高潮一二区| 欧美成人午夜免费资源| 精品国产乱码久久久久久小说| 久久久久国产精品人妻一区二区| 国产男女超爽视频在线观看| 一级毛片久久久久久久久女| 免费少妇av软件| 草草在线视频免费看| 少妇熟女欧美另类| 岛国毛片在线播放| 91在线精品国自产拍蜜月| 午夜免费男女啪啪视频观看| √禁漫天堂资源中文www| 十八禁高潮呻吟视频 | 午夜精品国产一区二区电影| 最新的欧美精品一区二区| 中文乱码字字幕精品一区二区三区| 国产精品一区二区在线观看99| 久久久久久久精品精品| 午夜免费观看性视频| 爱豆传媒免费全集在线观看| 精品人妻一区二区三区麻豆| 日本wwww免费看| 欧美日韩亚洲高清精品| 日本午夜av视频| 麻豆乱淫一区二区| 国产亚洲5aaaaa淫片| 简卡轻食公司| 日韩欧美 国产精品| 天堂8中文在线网| 免费黄频网站在线观看国产| freevideosex欧美| av卡一久久| 国产精品欧美亚洲77777| 王馨瑶露胸无遮挡在线观看| 成年av动漫网址| 国产成人精品福利久久| 亚洲国产精品专区欧美| 国产成人精品无人区| 蜜臀久久99精品久久宅男| √禁漫天堂资源中文www| 51国产日韩欧美| 99久久精品一区二区三区| 十八禁网站网址无遮挡 | 在线观看av片永久免费下载| 一本色道久久久久久精品综合| 色婷婷久久久亚洲欧美| 欧美激情国产日韩精品一区| 女人精品久久久久毛片| 乱系列少妇在线播放| 成年人免费黄色播放视频 | 国产淫片久久久久久久久| 精品少妇黑人巨大在线播放| 日本猛色少妇xxxxx猛交久久| 亚洲国产毛片av蜜桃av| 各种免费的搞黄视频| 精品亚洲成国产av| 97超视频在线观看视频| 在线观看一区二区三区激情| 久久人人爽人人爽人人片va| 国产欧美另类精品又又久久亚洲欧美| 久久精品国产亚洲av天美| 亚洲天堂av无毛| 免费观看的影片在线观看| 精品少妇黑人巨大在线播放| 中文字幕av电影在线播放| 伊人久久精品亚洲午夜| 亚洲欧美日韩卡通动漫| 大香蕉久久网| 亚洲高清免费不卡视频| 国产精品久久久久久久电影| 亚洲va在线va天堂va国产| 欧美日韩综合久久久久久| 亚洲国产最新在线播放| av.在线天堂| 日韩免费高清中文字幕av| 国产熟女欧美一区二区| 最近手机中文字幕大全| 国产有黄有色有爽视频| 美女cb高潮喷水在线观看| 国产有黄有色有爽视频| 在现免费观看毛片| 日韩av不卡免费在线播放| 大香蕉97超碰在线| 日本-黄色视频高清免费观看| 国产精品久久久久成人av| 久久女婷五月综合色啪小说| 亚洲综合精品二区| 三级国产精品欧美在线观看| 国产 精品1| 成人毛片60女人毛片免费| 在线 av 中文字幕| 国产黄色免费在线视频| 一二三四中文在线观看免费高清| 大又大粗又爽又黄少妇毛片口| 精品视频人人做人人爽| 看免费成人av毛片| 少妇被粗大猛烈的视频| 99久国产av精品国产电影| 日韩电影二区| 丝瓜视频免费看黄片| 国产免费福利视频在线观看| 欧美另类一区| 自线自在国产av| 制服丝袜香蕉在线| 欧美性感艳星| 国产精品久久久久久精品电影小说| 国精品久久久久久国模美| 在线亚洲精品国产二区图片欧美 | 日韩电影二区| 国产一区二区三区av在线| 亚洲精品国产成人久久av| 国内揄拍国产精品人妻在线| 精品一区在线观看国产| 国产无遮挡羞羞视频在线观看| 九九在线视频观看精品| 视频中文字幕在线观看| 久久狼人影院| 精品久久久久久电影网| 韩国高清视频一区二区三区| 亚洲第一区二区三区不卡| 黄色毛片三级朝国网站 | 丰满人妻一区二区三区视频av| 女性被躁到高潮视频| av天堂中文字幕网| 一区二区三区四区激情视频| 99久久精品一区二区三区| 人人妻人人澡人人看| 国产精品伦人一区二区| 国产黄色免费在线视频| 老司机影院成人| 久久久久久久久久人人人人人人| 免费观看无遮挡的男女| 亚洲性久久影院| 亚洲情色 制服丝袜| 精品久久久噜噜| 久久久久久伊人网av| 99热6这里只有精品| 美女大奶头黄色视频| 国产精品久久久久成人av| 女人久久www免费人成看片| 亚洲欧美日韩卡通动漫| 91精品一卡2卡3卡4卡| 日本猛色少妇xxxxx猛交久久| tube8黄色片| 日韩精品有码人妻一区| 国产精品久久久久久精品电影小说| 最近中文字幕2019免费版| 国产精品女同一区二区软件| 欧美精品高潮呻吟av久久| 精品人妻偷拍中文字幕| 精品久久久精品久久久| av有码第一页| h日本视频在线播放| 色吧在线观看| 欧美xxxx性猛交bbbb| 成年人免费黄色播放视频 | 啦啦啦视频在线资源免费观看| 亚洲精品一二三| 亚洲精品国产色婷婷电影| 大又大粗又爽又黄少妇毛片口| 国产精品秋霞免费鲁丝片| 久久久久久久国产电影| av播播在线观看一区| 久久久久久久精品精品| 欧美变态另类bdsm刘玥| 自拍欧美九色日韩亚洲蝌蚪91 | 国产精品秋霞免费鲁丝片| 狠狠精品人妻久久久久久综合| 街头女战士在线观看网站| 国产中年淑女户外野战色| 男的添女的下面高潮视频| 嫩草影院入口| 国产黄色视频一区二区在线观看| 久久6这里有精品| 久久av网站| 91久久精品国产一区二区三区| 蜜桃久久精品国产亚洲av| 国内少妇人妻偷人精品xxx网站| 少妇猛男粗大的猛烈进出视频| 少妇被粗大的猛进出69影院 | 又粗又硬又长又爽又黄的视频| 高清在线视频一区二区三区| 哪个播放器可以免费观看大片| 人妻系列 视频| 我的老师免费观看完整版| 亚洲欧美日韩卡通动漫| 赤兔流量卡办理| 一本色道久久久久久精品综合| 99久久人妻综合| 美女主播在线视频| 人妻人人澡人人爽人人| 午夜视频国产福利| 亚洲电影在线观看av| 精品久久久久久久久av| 黄色毛片三级朝国网站 | 亚洲av日韩在线播放| av卡一久久| 看十八女毛片水多多多| 成人18禁高潮啪啪吃奶动态图 | 观看美女的网站| a级毛色黄片| 日韩欧美一区视频在线观看 | 亚洲国产毛片av蜜桃av| 亚洲国产精品专区欧美| 18禁动态无遮挡网站| 寂寞人妻少妇视频99o| 一本大道久久a久久精品| 日韩熟女老妇一区二区性免费视频| 国产精品欧美亚洲77777| 丝瓜视频免费看黄片| 精品国产乱码久久久久久小说| 狂野欧美白嫩少妇大欣赏| 国产av码专区亚洲av| 国精品久久久久久国模美| 欧美高清成人免费视频www| 又粗又硬又长又爽又黄的视频| 新久久久久国产一级毛片| 免费高清在线观看视频在线观看| 我要看黄色一级片免费的| 免费观看在线日韩| 中文乱码字字幕精品一区二区三区| 国产免费福利视频在线观看| 精品少妇内射三级| 麻豆成人av视频| 夫妻午夜视频| 夜夜爽夜夜爽视频| 少妇人妻久久综合中文| 国产精品免费大片| 曰老女人黄片| 大陆偷拍与自拍| 丰满少妇做爰视频| 久久久国产精品麻豆| 啦啦啦中文免费视频观看日本| av视频免费观看在线观看| 一级爰片在线观看| 亚洲精品aⅴ在线观看| 18禁在线无遮挡免费观看视频| 黄色一级大片看看| 大片免费播放器 马上看| 日韩熟女老妇一区二区性免费视频| 少妇裸体淫交视频免费看高清| 18+在线观看网站| 亚洲av二区三区四区| 亚洲精品亚洲一区二区| 永久网站在线| 美女内射精品一级片tv| 99国产精品免费福利视频| 中文字幕av电影在线播放| 免费av不卡在线播放| 久久精品久久精品一区二区三区| 亚洲中文av在线| 亚洲婷婷狠狠爱综合网| 夜夜看夜夜爽夜夜摸| 在线 av 中文字幕| 国产永久视频网站| 丝袜脚勾引网站| 国产免费一级a男人的天堂| 最近的中文字幕免费完整| 亚洲欧美日韩东京热| 91精品伊人久久大香线蕉| 五月开心婷婷网| 欧美日韩国产mv在线观看视频| 男女免费视频国产| av女优亚洲男人天堂| 国产女主播在线喷水免费视频网站| 国产av国产精品国产| 热99国产精品久久久久久7| 国产成人精品福利久久| 精品少妇久久久久久888优播| 久久亚洲国产成人精品v| 国国产精品蜜臀av免费| 久久国产精品男人的天堂亚洲 | 高清不卡的av网站| 久久精品国产亚洲av涩爱| 亚洲情色 制服丝袜| 日韩欧美一区视频在线观看 | 国产免费一级a男人的天堂| 日本爱情动作片www.在线观看| 伦精品一区二区三区| 日韩成人av中文字幕在线观看| 97超碰精品成人国产| 免费高清在线观看视频在线观看| 久久久精品94久久精品| 亚洲不卡免费看| 最新的欧美精品一区二区| 99九九线精品视频在线观看视频| 成人影院久久| 国产色婷婷99| 久久久久久久久大av| 国产精品麻豆人妻色哟哟久久| 亚洲内射少妇av| av专区在线播放| 久久ye,这里只有精品| 熟女av电影| 一级毛片久久久久久久久女| 日日摸夜夜添夜夜添av毛片| 中国国产av一级| 国产在线视频一区二区| 美女xxoo啪啪120秒动态图| 国产午夜精品一二区理论片| 国产亚洲91精品色在线| 青春草视频在线免费观看| 亚洲内射少妇av| 成人午夜精彩视频在线观看| a级毛片免费高清观看在线播放| 少妇被粗大的猛进出69影院 | 精品卡一卡二卡四卡免费| 午夜福利在线观看免费完整高清在| 老司机亚洲免费影院| 日日啪夜夜撸| 亚洲欧美日韩另类电影网站| 观看免费一级毛片| 十分钟在线观看高清视频www | 国产免费一区二区三区四区乱码| 高清视频免费观看一区二区| 成人影院久久| 尾随美女入室| 啦啦啦中文免费视频观看日本| 日韩,欧美,国产一区二区三区| av在线播放精品| 精品酒店卫生间| 亚洲成人手机| 亚洲成色77777| 国产精品嫩草影院av在线观看| 国产精品一区二区性色av| 欧美精品亚洲一区二区| 欧美日韩视频精品一区|